Human Papilloma Virus Vaccine: Future of Cervical Cancer Prevention

  • Jannatul Fardows Assistant Professor, Department of Microbiology, International Medical College, Gazipur
  • Naznin Nehar Lecturer, Department of Virology, Dhaka Medical College, Dhaka
  • Nurjahan Laskar Assistant Professor, Department of Microbiology, International Medical College, Gazipur
  • Samsoon Nahar Joly Assistant Professor, Department of Microbiology, Kumudini Women?s Medical College, Tangail
Keywords: Human papilloma virus, Cervical cancer, Vaccine, Cervarix, Gardasil, Efficacy

Abstract

Cervical cancer is a deadly cancer that clutches lives of the women in most of the cases due to lack of consciousness about the disease in the developing countries. It remains a threat which is second only to breast cancer in overall disease burden for women throughout the world. Cervical cancer is almost a preventable disease by prophylactic vaccine and routine screening. Both Cervarix and Gardasil vaccines have been effective in preventing persistent infection with targeted HPV types and in preventing cervical intraepithelial lesions. It is safe and nearly 100% effective if given before onset of sexual activity. This review article is aimed to explore different aspects of this vaccine as well as to develop awareness among health professionals of different disciplines.

J Enam Med Col 2016; 6(3): 157-160

Downloads

Download data is not yet available.
Abstract
1866
PDF
899

Author Biography

Jannatul Fardows, Assistant Professor, Department of Microbiology, International Medical College, Gazipur


Published
2016-10-20
How to Cite
Fardows, J., Nehar, N., Laskar, N., & Joly, S. (2016). Human Papilloma Virus Vaccine: Future of Cervical Cancer Prevention. Journal of Enam Medical College, 6(3), 157-160. https://doi.org/10.3329/jemc.v6i3.29683
Section
Review Article